Rubfila International Limited Reports ₹133 Crore June Sales, Down 7.9%

Rubfila International Limited reported consolidated revenue from operations of ₹133 crore for the quarter ended June 2026, down 7.9% from ₹145 crore a year earlier, while net profit declined 13.3% to ₹5.8 crore. The result followed revenue of ₹161 crore in the March 2026 quarter and indicates a slower start to FY27.

What did Rubfila International report for the June 2026 quarter?

Rubfila International reported ₹133 crore in consolidated sales for the June 2026 quarter, compared with ₹145 crore in the June 2025 quarter and ₹161 crore in the preceding March 2026 quarter. Revenue was therefore lower by 7.9% year on year and 16.88% quarter on quarter, based on the reported quarterly data.

Consolidated net profit was ₹5.8 crore, versus ₹6.7 crore in the corresponding quarter a year earlier, a year-on-year decline of 13.3%. The company also reported quarterly operating profit of ₹9.33 crore, compared with ₹9.86 crore in June 2025. Operating margin improved marginally to 6.99% from 6.80% a year earlier, even as sales declined.

The earnings release dated August 11, 2026 reported earnings per share of ₹1.07 and revenue of ₹1.33 billion, equivalent to ₹133 crore. The reported quarterly net income of ₹58 million is equivalent to ₹5.8 crore. Rubfila International is an Indian manufacturer of extruded round latex rubber thread.

How did the quarter compare with recent performance?

Rubfila International's June 2026 sales of ₹133 crore were below the ₹150 crore reported in September 2025, ₹147 crore in December 2025 and ₹161 crore in March 2026. The March 2026 quarter was the highest sales figure in the eight-quarter consolidated series provided, before revenue moved lower in June.

Operating profit also declined sequentially, from ₹11.04 crore in March 2026 to ₹9.33 crore in June 2026. However, the operating margin rose slightly from 6.87% to 6.99% over the same period because expenses fell to ₹124 crore from ₹150 crore. Other income was ₹1.43 crore in June 2026, compared with ₹2.07 crore in the March quarter.

What does the annual revenue record show?

Rubfila International's reported total revenue reached ₹602.50 crore in the year ended March 2026, up 9.46% from ₹550.41 crore in the previous year. Gross profit increased 7.24% to ₹152.73 crore from ₹142.42 crore over the same period.

The annual figures show that revenue had risen 17.16% in FY25 after a smaller 2.78% increase in FY24. Gross profit had declined in FY23 and FY24 before returning to growth in FY25 and FY26. This context makes the June-quarter decline relevant because it follows two years of annual revenue expansion.

What are the business and investor implications of the results?

The June-quarter numbers show lower revenue and profit than both the prior-year and immediately preceding quarters, while operating margin remained close to 7%. For investors, the figures provide the first reported quarterly financial update for FY27 and establish a lower revenue base than the March 2026 quarter.

Rubfila International's sales depend on operations in the latex rubber thread segment. The reported data does not specify the reasons for the quarterly decline, and it does not provide a revenue or earnings forecast. As a result, the results establish the reported movement in sales, profit and operating margin but do not confirm the drivers behind the change.

The company has also disclosed the divestment of its entire shareholding in subsidiary Premier Tissues (India) Limited to a related party. The supplied information does not state the transaction value, completion date or financial impact. Those details would be relevant for assessing any effect on the group's future consolidated operations.

Conclusion

Rubfila International began FY27 with consolidated June-quarter sales of ₹133 crore and net profit of ₹5.8 crore, both lower than a year earlier. At the same time, its 6.99% operating margin was marginally ahead of the June 2025 level, and its FY26 annual revenue had grown 9.46% to ₹602.50 crore.

The next quarterly result will show whether the June decline was followed by a recovery in sales and operating profit. Investors can also watch for additional disclosures on the Premier Tissues (India) Limited divestment, including its value, timing and effect on consolidated financial statements.